Related Experiment Videos
Circulating platelets show increased activation in patients with acute cerebral ischemia
J A Zeller1, D Tschoepe, C Kessler
1Department of Neurology, Christian-Albrechts-University, Kiel, Germany. j.zeller@neurologie.uni-kiel.de
Thrombosis and Haemostasis
|April 2, 1999
Summary
Platelet activation markers differ based on acute cerebral ischemia cause. Atherosclerosis patients showed higher activation than controls, unlike cardioembolic stroke patients, aiding diagnosis and therapy monitoring.
Area of Science:
- Neuroscience
- Hematology
- Cardiovascular Medicine
Background:
- Platelet activation is crucial in arterial stenosis, including coronary heart disease.
- Its role in acute cerebral ischemia (ACI), especially with large vessel disease, is significant.
- Flow cytometry for platelet activation markers in ACI has not been evaluated.
Purpose of the Study:
- To evaluate flow cytometric detection of platelet adhesion molecules in ACI patients.
- To assess platelet activation profiles across different ACI etiologies.
- To explore diagnostic potential for monitoring anti-platelet therapy and stratifying stroke patients.
Main Methods:
- Studied 72 ACI patients and 72 controls.
- Used flow cytometry with monoclonal antibodies against CD62, CD63, and thrombospondin.
- Measured exposure of activation-dependent platelet adhesion molecules.
Main Results:
- Platelet activation varied significantly by ACI etiology.
- Patients with atherosclerosis of brain-supplying arteries showed higher activation marker expression than controls.
- Patients with cardioembolic stroke did not exhibit increased platelet activation compared to controls.
Conclusions:
- Platelet adhesion molecule analysis can define activation profiles in ACI.
- This method may aid in monitoring personalized anti-platelet therapy.
- It holds potential for differentiating stroke patient subgroups.